ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,464,000 | -24.0% | 198,100 | -54.9% | 0.15% | -9.3% |
| Q2 2016 | $3,242,000 | +84.3% | 438,817 | +55.9% | 0.16% | +95.2% |
| Q4 2015 | $1,759,000 | -3.7% | 281,552 | +27.4% | 0.08% | +36.1% |
| Q2 2015 | $1,827,000 | -20.6% | 221,003 | -20.9% | 0.06% | -22.8% |
| Q1 2015 | $2,301,000 | +253.5% | 279,267 | +131.4% | 0.08% | +163.3% |
| Q3 2014 | $651,000 | -85.8% | 120,670 | -78.8% | 0.03% | -87.7% |
| Q1 2014 | $4,582,000 | +35.9% | 568,559 | +210.0% | 0.24% | +32.1% |
| Q3 2013 | $3,372,000 | – | 183,377 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |